Skip to main content
Signal8
Kohli Prashant profile photo

Prashant Kohli

CIK: 0001946739

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Grace Therapeutics, Inc. logo
GRCE

Grace Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Grace Therapeutics, Inc. logo
    GRCE

    Grace Therapeutics, Inc.

    Sep 9, 2026
    Purchase(P)
    Direct
    100K shares at avg. $2.14$214K
  • Grace Therapeutics, Inc. logo
    GRCE

    Grace Therapeutics, Inc.

    Aug 28, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    267.2K shares-
  • Grace Therapeutics, Inc. logo
    GRCE

    Grace Therapeutics, Inc.

    Apr 14, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    225.4K shares-

1-3 of 3

About Kohli Prashant

Kohli Prashant (SEC CIK 0001946739) files insider reports with the SEC as Chief Executive Officer of Grace Therapeutics, Inc. (GRCE).

Signal8 holds 3 ownership filings by Kohli Prashant, all Form 4s, filed between Apr 16, 2025 and Sep 10, 2026. Those filings report 3 transactions, from Apr 14, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kohli Prashant's filings is in PRINCETON, NJ.

Recent filings by Kohli Prashant

  • Sep 9, 2026: Open-market purchase of GRCE shares (Form 4, code P).
  • Aug 28, 2026: Grant or award of GRCE derivative securities (Form 4, code A).
  • Apr 14, 2025: Grant or award of GRCE derivative securities (Form 4, code A).

Other insiders filing for Grace Therapeutics, Inc. (GRCE)

How to read Form 4 transaction codes